Premium
Telomerase activity in Stage II colorectal carcinoma
Author(s) -
KawanishiTabata Rika,
Lopez Francisco,
Fratantonio Sam,
Kim Nam,
Goldblum John,
Tubbs Raymond,
Elson Paul,
Lavery Ian,
Bukowski Ronald M.,
Ganapathi Ram,
Ganapathi Mahrukh K.
Publication year - 2002
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.10911
Subject(s) - telomerase , colorectal cancer , medicine , stage (stratigraphy) , rectum , oncology , carcinogenesis , telomere , carcinoma , ribonucleoprotein , univariate analysis , gastroenterology , cancer , pathology , multivariate analysis , biology , rna , gene , genetics , paleontology
Abstract BACKGROUND Telomerase is a ribonucleoprotein polymerase that adds telomeric repeats to chromosome ends. This enzyme is deficient in the majority of normal somatic cells, but often is reactivated during tumorigenesis. In the current study, the authors examined telomerase activity in human American Joint Committee on Cancer Stage II colorectal carcinomas and correlated it with traditional prognostic indicators and disease outcome. METHODS The telomerase repeat amplification protocol (TRAP) was employed to determine telomerase activity in 122 surgical specimens (from 77 male and 45 female patients) of human Stage II colorectal carcinoma. The primary site of the tumor was the colon in 52 cases and the rectum in 70 cases. Telomerase activity was correlated with traditional prognostic indicators such as gender, age, T classification, tumor size, tumor grade, and disease outcome (overall survival and disease‐free survival). The Median follow‐up for patients who still were alive was 5.8 years. RESULTS Telomerase activity was detected in 80% of the tumors (98 of 122 tumors). Telomerase‐positive patients differed from telomerase‐negative patients in that they tended to be female (41% vs. 21%; P = 0.1), presented with primary tumors of the colon more frequently (49% vs. 17%; P = 0.01), and had a higher T classification (T 4 ) (62% vs. 38%; P = 0.04). Univariate and multivariate analyses demonstrated a correlation between telomerase activity and disease‐free survival ( P = 0.05). CONCLUSIONS Although a large percentage of Stage II colorectal carcinoma samples were positive for telomerase activity, the prognosis for patients with telomerase‐negative tumors was found to be worse than that for patients with telomerase‐positive tumors. Cancer 2002;95:1834–9. © 2002 American Cancer Society. DOI 10.1002/cncr.10911